clinical trial · NCT05387980
A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
Pfizer·—·active not recruiting·n = 1,128
Atopic DermatitisCIBINQO
brief summary
The purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.
started
Apr 19, 2022
primary completion
Nov 1, 2028
completion
Nov 1, 2028
last updated
Mar 19, 2026
official title
CIBINQO® TABLETS SPECIAL INVESTIGATION
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol